At the basic research level, researchers have identified the HLA-A2-restricted epitope p286-1Y2L9L derived from MAGE-A4, which can induce specific cytotoxic T lymphocytes (CTLs) capable of killing MAGE-A4-positive tumor cells. This evidence concerns the gene MAGEA4 and neoplasm.